Literature DB >> 21349817

Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.

Qiaoyuan Yang1, Zhigang Jie, Hong Cao, Anne R Greenlee, Chengfeng Yang, Fei Zou, Yiguo Jiang.   

Abstract

Gastric cancer is the fourth most common cancer and the second leading cause of cancer mortality worldwide but the underlying molecular mechanism is not entirely clear. The objective of this study was to explore the role of let-7a microRNA (miRNA) in gastric tumorigenesis and the possible correlation between RAB40C and let-7a miRNA in gastric cancer. We found that expression of let-7a is reduced in human gastric cancer tissues and cell lines and there was a significant correlation between the level of let-7a expression and the stage of differentiation. Overexpression of let-7a resulted in a decrease in cell proliferation and G(1) arrest, significantly suppressed anchorage-dependent growth in vitro and the tumorigenicity of gastric cancer cells in a nude mouse xenograft model. Furthermore, we demonstrated that RAB40C is regulated directly by let-7a and plays an essential role as a mediator of the biological effects of let-7a in gastric tumorigenesis. This study revealed that let-7a is significant in suppressing gastric cancer growth in vivo and in vitro and provided the first evidence that RAB40C is negatively regulated by let-7a at the posttranscriptional level via binding to the 3'-untranslated region of RAB40C messenger RNA in gastric cancer. The results of this study suggest that let-7a and RAB40C are potentially useful targets for gastric cancer diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349817     DOI: 10.1093/carcin/bgr035

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  48 in total

Review 1.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 2.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 3.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

4.  miR-519d-3p Inhibits Cell Proliferation and Invasion of Gastric Cancer by Downregulating B-Cell Lymphoma 6.

Authors:  Yong-Yuan Li; Jian-Ping Shao; Shu-Peng Zhang; Guo-Qiang Xing; Hong-Jie Liu
Journal:  Cytogenet Genome Res       Date:  2018-03-07       Impact factor: 1.636

Review 5.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

Review 6.  Finding cancer-associated miRNAs: methods and tools.

Authors:  Anastasis Oulas; Nestoras Karathanasis; Annita Louloupi; Panayiota Poirazi
Journal:  Mol Biotechnol       Date:  2011-09       Impact factor: 2.695

Review 7.  MicroRNA control of epithelial-mesenchymal transition and metastasis.

Authors:  Jinsong Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 8.  MiRNA as potential biomarkers and therapeutic targets for gastric cancer.

Authors:  Vivian Yvonne Shin; Kent-Man Chu
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

9.  Dysregulated Expression of Apoptosis-Associated Genes and MicroRNAs and Their Involvement in Gastric Carcinogenesis.

Authors:  Mayara Luciana Sallas; Diana Zapparoli; Mônica Pezenatto Dos Santos; Jéssica Nunes Pereira; Wilson Aparecido Orcini; Rita Luiza Peruquetti; Elizabeth Suchi Chen; Marilia de Arruda Cardoso Smith; Spencer Luiz Marques Payão; Lucas Trevizani Rasmussen
Journal:  J Gastrointest Cancer       Date:  2021-06

Review 10.  Role of microRNAs in gastric cancer.

Authors:  Hideyuki Ishiguro; Masahiro Kimura; Hiromitsu Takeyama
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.